Nevena Damjanov

4.8k citations
59 papers · 1.4k indexed · h-index 21
  • Oncology top 5%
    • Colorectal Cancer Treatments and Studies 12
    • Cancer Treatment and Pharmacology 11
    • Pancreatic and Hepatic Oncology Research 9
  • Hepatology top 10%
    • Hepatocellular Carcinoma Treatment and Prognosis 6
    • Gastric Cancer Management and Outcomes 8
    • Lung Cancer Treatments and Mutations 8
  • Surgery top 10%
    • Cholangiocarcinoma and Gallbladder Cancer Studies 11
    • Fibroblast Growth Factor Research 6

Nevena Damjanov

57 papers receiving 1.4k citations

Peers

Nevena Damjanov
Comparison fields: 5 of 88
  • Oncology 789
  • Otorhinolaryngology 72
  • Hepatology 112
  • Pulmonary and Respiratory Medicine 368
  • Surgery 454
Replace Ruth Vera with:
Ruth Vera Spain
Jun‐Eul Hwang South Korea
Scott Ernst Canada
Vanita Noronha India
Wei Chua Australia
Yixin Zhou China
Mitsue Saito Japan
Yan Song United States
Mark Doherty Canada
P. Thirion Ireland
Nevena Damjanov relative to Ruth Vera Spain Ruth Vera's profile →
Citations per field
00.5×1.7×
Ruth Vera · 1×
Citations per year

Countries citing papers authored by Nevena Damjanov

Since Specialization
Citations

This map shows the geographic impact of Nevena Damjanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nevena Damjanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nevena Damjanov more than expected).

Fields of papers citing papers by Nevena Damjanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nevena Damjanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nevena Damjanov. The network helps show where Nevena Damjanov may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nevena Damjanov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nevena Damjanov Line = papers co-authored together Nevena Damjanov links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20236
3 20231
4 20233
5 202210
6 202114
7 202019
8 202011
9 201834
10 2018265
11 201721
12 201710
13 201731
14 201735
15 201733
16 201623
17 201515
18 20141
19 201369
20 200856

About Nevena Damjanov

Nevena Damjanov is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Cancer Treatment and Pharmacology (11 papers), Pancreatic and Hepatic Oncology Research (9 papers), Gastric Cancer Management and Outcomes (8 papers), Lung Cancer Treatments and Mutations (8 papers), Fibroblast Growth Factor Research (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). The work is most often cited by research in Oncology (789 citations), Otorhinolaryngology (72 citations) and Hepatology (112 citations). Nevena Damjanov has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Andrea B. Troxel, Bonnie Ky, Kerry S. Courneya, Kathryn H. Schmitz, Justin C. Brown, Andrew D. Rhim, Anil K. Rustgi, Babette S. Zemel, Michael R. Rickels and Neal J. Meropol. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026